REQUEST A QUOTE
CART(0)
Products for Quality Control
HOME
ABOUT US
PRODUCTS
Reference Standards
Drug Inhibitors
Drugs Intermediates
Isotope Compounds
By Category
By APIs Name
SERVICE
ORDER
NEWS
CONTACT US
Search
Products
Home > Products
Bezafibrate EP Impurity C
QCC Cat No.:
QB052603
Chemical Name:
Bezafibrate EP Impurity C
Synonyms:
methyl 2-(4-(2-(4-chlorobenzamido)ethyl)phenoxy)-2-methylpropanoate
CAS No.:
2157488-46-3
Molecular Formula:
C20H22ClNO4
Molecular Weight:
375.85
================================================
Standard Reference Material For "Bezafibrate EP Impurity C"
Warning:
The form of the product salt may be different from the official website,please consult your local agent for details.
Related Products:
· Bezafibrate Impurity 9
· Bezafibrate Impurity 8
· Bezafibrate Impurity 7
· Bezafibrate Impurity 6
· Bezafibrate
· Bezafibrate EP Impurity E
· Bezafibrate EP Impurity D
· Bezafibrate EP Impurity A
· Indometacin EP Impurity A;
Bezafibrate EP Impurity B;
Acemetacin EP Impurity A;
Clopamide EP Impurity B
RELATED PRODUCTS
QCC CAT#
COMPOUND
ORDER
QB052609
Bezafibrate Impurity 9
CAS# 883800-52-0
M.F.: C15H14ClNO2
M.W.: 275.73
Details
QB052608
Bezafibrate Impurity 8
CAS# 84491-96-3
M.F.: C15H14ClNO2
M.W.: 275.73
Details
QB052607
Bezafibrate Impurity 7
CAS# 55458-78-1
M.F.: C12H17NO3
M.W.: 223.27
Details
QB052606
Bezafibrate Impurity 6
CAS# 41859-56-7
M.F.: C22H17Cl2NO3
M.W.: 414.28
Details
QB052600
Bezafibrate
CAS# 41859-67-0
M.F.: C19H20ClNO4
M.W.: 361.82
Details
QB052605
Bezafibrate EP Impurity E
CAS# NA
M.F.: C23H28ClNO4
M.W.: 417.93
Details
QB052604
Bezafibrate EP Impurity D
CAS# 41859-58-9
M.F.: C21H24ClNO4
M.W.: 389.87
Details
QB052601
Bezafibrate EP Impurity A
CAS# 41859-57-8
M.F.: C15H14ClNO2
M.W.: 275.73
Details
QI140401
Indometacin EP Impurity A;
Bezafibrate EP Impurity B;
Acemetacin EP Impurity A;
Clopamide EP Impurity B
CAS# 74-11-3
M.F.: C7H5ClO2
M.W.: 156.57
Details
×
Add to cart
Specifications
g
mg
Quantity
ADD
DISCLAIMER | PRIVACY POLICY | TERMS OF USE
© QUALITY CONTROL CHEMICALS INC. ALL RIGHTS RESERVED.